SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030837
Filing Date
2019-08-08
Accepted
2019-08-08 16:31:21
Documents
56
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eigr-10q_20190630.htm 10-Q 1940500
2 EX-31.1 eigr-ex311_11.htm EX-31.1 16849
3 EX-31.2 eigr-ex312_10.htm EX-31.2 16913
4 EX-32.1 eigr-ex321_9.htm EX-32.1 5746
  Complete submission text file 0001564590-19-030837.txt   6276728

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT eigr-20190630.xml EX-101.INS 1338486
6 XBRL TAXONOMY EXTENSION SCHEMA eigr-20190630.xsd EX-101.SCH 45724
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eigr-20190630_cal.xml EX-101.CAL 44716
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eigr-20190630_def.xml EX-101.DEF 129905
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eigr-20190630_lab.xml EX-101.LAB 347474
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eigr-20190630_pre.xml EX-101.PRE 258139
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36183 | Film No.: 191010019
SIC: 2836 Biological Products, (No Diagnostic Substances)